• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO BYPASS SYSTEM; INTRAOCULAR PRESSURE LOWERING IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO BYPASS SYSTEM; INTRAOCULAR PRESSURE LOWERING IMPLANT Back to Search Results
Model Number G2-W-JP
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
It was reported that following a left eye (os) trabecular microbypass stent procedure, the surgeon observed that one (1) of the two (2) stents was strayed into the superior choroidal space.Postoperatively, there were no complications and the intraocular pressure improved (iop decreased).The dislodged stent remains in the patient eye, viewed in the suprachoroidal via computed tomography (ct).Additional information has been requested.
 
Manufacturer Narrative
Additional information: the device was not available; therefore, product testing on the actual device could not be performed.The device history record review of the manufacturing lot was performed and there were no non-conformities found to be related to the reported event.A review of the device labeling was completed.Dislodged stent is identified in the labeling as a known inherent risk of trabecular micro-bypass stent procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.Based on the information received, the root cause of the reported event could not be conclusively identified.Mfr# reference: (b)(4).
 
Manufacturer Narrative
Additional information: b5, b6, g3, g4.Based on the information received, the root cause of the reported event was due to patient''s condition.Mfr# reference: (b)(4).
 
Event Description
Through follow-up, the surgeon reiterated that computed tomography (ct) scans identified two (2) stents, and reported that the intraocular pressure (iop) decreased with no postoperative complications or any adverse patient impact.The report noted patient anatomy precluded implantation.The patient''s most recent status was described as "no hyphema or iop increase" and the patient is continuing to be monitored.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISTENT INJECT W TRABECULAR MICRO BYPASS SYSTEM
Type of Device
INTRAOCULAR PRESSURE LOWERING IMPLANT
Manufacturer (Section D)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer Contact
229 avenida fabricante
san clemente, CA 92672
949367960
MDR Report Key15294635
MDR Text Key305587023
Report Number2032546-2022-00094
Device Sequence Number1
Product Code OGO
UDI-Device Identifier00853704002340
UDI-Public0100853704002340
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P170043
Number of Events Reported123
Summary Report (Y/N)Y
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG2-W-JP
Device Lot Number303239
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age73 YR
Patient SexMale
-
-